Localized Prostate Cancer
Advertisement
A study arm from the phase 3 EMBARK trial evaluating enzalutamide for nmCSPC with high-risk BCR has had positive outcomes.
A recent study analyzed a 15-year follow-up in men with prostate cancer to gauge the effectiveness of different treatments.
This review highlights the research on the costs related to the treatment of localized PC and the associated outcomes.
Phouc Tran, MD, PhD, highlights the challenges of accurate risk stratification for newly diagnosed localized prostate cancer.
David Nanus, MD, details the ways in which PSMA PET varies in guidelines and is used to stage localized prostate cancer.
A recent update on the phase 3 MIRAGE trial determined if MRI or CT-guided stereotactic body radiotherapy is most effective.
With a lack of trials that address different surgical options for localized PC, is there evidence to guide patients?
A recent study investigated the role of FACIT-F as a baseline predictor for OS in patients undergoing SBRT for localized PCa.
A prospective study assessed the 4Kscore’s ability to predict prostate cancer tumor progression on active surveillance.
18F-sodium fluoride positron emission tomography-computed tomography may better detect skeletal metastases in patients
The use of primary whole gland cryoablation had excellent outcomes among men with localized prostate cancer.
Active surveillance and enzalutamide monotherapy for localized prostate cancer is compared with active surveillance alone.
The rate of prostate cancer after high-frequency irreversible electroporation ablation was lower than other energy platforms.
The propensity score matching investigated the medical expenditure of RP and IMRT in elderly patients with high-risk LPC.
The mental health data comes from one of the largest randomized-controlled trials to date.
The therapy represents a valuable strategy in select patients whose disease fails to respond to initial cryoablation or HIFU.
The results highlight the need for urologists to consider baseline urinary symptoms in treatment decision-making.
Advertisement
670 Madison Ave.
Manalapan, NJ 07726